Every 10-Q that Oklo Inc. (OKLO) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow OKLO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OKLO filings page.
Oklo Inc. is still in the development stage but began generating modest revenue, recording $1.21 million (in thousands) for the three and six months ended June 30, 2026, compared with none a year earlier. Operating expenses rose sharply, led by $39.47 million in research and development and $34.21 million in general and administrative costs for the quarter, resulting in a quarterly net loss of $48.54 million and a six‑month net loss of $81.60 million.
Liquidity is substantial: as of June 30, 2026, cash, cash equivalents, and marketable debt securities totaled $3.01 billion, supported by at-the-market equity programs that issued 23.1 million shares and raised net proceeds of $1.85 billion in the first half. Management states this balance is expected to fund operations for at least one year after the financial statements’ issuance.
Oklo continued to invest heavily in its advanced fission ecosystem. It acquired ARMEC and Creative Engineers for aggregate consideration of $33.38 million, adding precision manufacturing and chemical process engineering capabilities, and now carries $44.20 million of intangible assets and $16.54 million of goodwill. The company advanced multiple strategic projects, including its Aurora powerhouse, fuel recycling initiatives, and radioisotope production, highlighted by the Groves Isotope Test Reactor reaching startup authorization and first criticality shortly after quarter-end.
Oklo Inc. filed an amended quarterly report for the period ended March 31, 2026, solely to correct the conformed signature on the CFO’s certification; the underlying financial and other information remains unchanged from the original filing.
For the quarter, Oklo reported a net loss of $33.1 million, or $0.19 per share, as it continues to invest heavily in developing advanced fission powerhouses, fuel recycling, and radioisotope production. Research and development expenses rose to $27.0 million and general and administrative costs to $24.2 million, reflecting headcount growth and higher stock-based compensation.
Despite ongoing losses, Oklo’s liquidity strengthened significantly, with $2.54 billion in cash, cash equivalents, and marketable debt securities and $2.70 billion in total assets, largely driven by raising about $1.18 billion of net proceeds through an at-the-market equity program. The company expects its current cash resources to fund operations for at least one year while it advances key regulatory milestones, fuel facilities, and customer agreements for its Aurora powerhouses and isotope business.
Oklo Inc. reported a larger quarterly loss as it accelerated investment and strengthened its balance sheet. For the three months ended March 31, 2026, the company posted a net loss of $33.1 million, compared with $9.8 million a year earlier, as research and development and general and administrative expenses rose to $27.0 million and $24.2 million, respectively.
Higher spending reflects headcount growth and sharply increased stock-based compensation, while interest and dividend income climbed to $21.3 million on a much larger cash and securities base. Oklo finished the quarter with $2.54 billion in cash, cash equivalents, and marketable debt securities and total assets of $2.70 billion, against modest liabilities of $64.9 million, leaving stockholders’ equity at $2.64 billion.
The company completed a 2025 at-the-market equity program in Q1 2026, issuing about 12.4 million shares for net proceeds of roughly $1.18 billion, and used $17.9 million of cash in operating activities and $32.8 million for capital expenditures. Management believes existing liquidity will fund operations for at least one year as Oklo advances its Aurora fast fission powerhouses, fuel recycling and fabrication projects, and radioisotope initiatives.
Oklo Inc. reported third-quarter 2025 results marked by higher spending to advance its advanced fission projects and strong liquidity after capital raises. Net loss was $29.7 million for Q3, driven by operating expenses of $36.3 million (research and development $14.9 million; general and administrative $21.4 million). Interest and dividend income contributed $7.1 million in the quarter.
Liquidity strengthened materially: as of September 30, 2025, cash, cash equivalents, and marketable debt securities totaled $1.18 billion. The company completed an underwritten public offering for net proceeds of $440.1 million and sold shares via its at-the-market program for net proceeds of $526.1 million during the period. Oklo acquired Atomic Alchemy for total consideration of $28.4 million, recording $27.5 million of indefinite‑lived IPR&D and $6.7 million of goodwill. A $25.0 million right‑of‑first‑refusal liability reflects an LOI tied to future power sales capacity. Class A common shares outstanding were 156,247,075 as of November 7, 2025.
Oklo Inc. is advancing its Aurora fast‑reactor program and expanded into radioisotopes by acquiring Atomic Alchemy for $28,424 thousand (stock consideration $27,408 thousand and $900 thousand cash). The acquisition preliminarily allocated $27,500 thousand to indefinite‑lived IPR&D (two projects, Abundantia $4,600k and Meitner $22,900k) and $6,720 thousand to goodwill.
On the balance sheet as of June 30, 2025, Oklo held total cash, cash equivalents and marketable debt securities of $682,965 thousand (cash $226,771k; marketable debt securities fair value $456,194k). For the six months ended June 30, 2025 the company reported a net loss of $34,495 thousand, loss from operations of $45,889 thousand, net cash used in operating activities of $30,714 thousand, and an accumulated deficit of $169,604 thousand. In June 2025 Oklo completed a public offering of 7,666,667 shares at $60.00 per share, raising gross proceeds of $460,000 thousand and net proceeds of $441,600 thousand. Management states existing liquidity is expected to fund operations for at least one year following these condensed financial statements.